Safety of anti-TNF agents in patients with compensated cirrhosis: a case-control study

BACKGROUND: There is limited data on the use of anti-TNF agents in patients with concomitant cirrhosis. The aim of this study is to assess the safety of anti-TNF agents in patients with compensated cirrhosis who used these medications for the treatment of an underlying rheumatologic condition or IBD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapila, Nikhil, Gonzalez, Adalberto, Rosado, Jose Melendez, Flocco, Gianina, Salomon, Fayssa, Abusaif, Mohammad, Hussain, Ishtiaq, Moor, Molly A., Modaresi-Esfeh, Jamak, Castro, Fernando J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543557/
https://www.ncbi.nlm.nih.gov/pubmed/34707687
http://dx.doi.org/10.1177/17562848211037094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543557/
https://www.ncbi.nlm.nih.gov/pubmed/34707687
http://dx.doi.org/10.1177/17562848211037094

Ejemplares similares